Infectious Disease Doctors in Delaware Medicare Details, Address, Contact
23 Infectious Disease doctors found. Showing 21 - 23
 Susan Szabo, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 N Washington St, Wilmington, DE 19801 Phone: 302-255-1300 Fax: 302-255-1374 |
 William Patrick Mazur, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 N Washington St, Wilmington, DE 19801 Phone: 302-320-1300 Fax: 302-320-1374 |
Kirsten Andrea Hauer, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3301 Lancaster Pike, Suite 9, Wilmington, DE 19805 Phone: 302-661-2303 Fax: 302-661-2324 |
News Archive
New PCA-Rx therapy provides natural toxin removal treatment to Alzheimer's patients
According to the Alzheimer's Association, over 5 million Americans are afflicted with Alzheimer's disease. While its cause is controversial, many people believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been patients' primary option.
Discussion paper shows sharing health information could help improve health care, reduce costs
Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
Sanofi-aventis announces study results comparing efficacy of Lantus to detemir
Sanofi-aventis announced today results of a head-to-head study providing further evidence on the efficacy of once-daily, 24-hour basal insulin Lantus(R) (insulin glargine (rDNA) injection) compared to twice-daily insulin detemir. The study was presented during the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.
Medical or surgical treatment for severe heartburn prevents esophageal cancer
Medical or surgical treatment of severe heartburn prevents cancer of the esophagus, a study from Karolinska Institutet with almost one million Nordic patients reveals. The results will be published in the scientific journal JAMA Oncology.
Shield signs strategic commercialization agreement for ST10-021 iron therapy product
Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has signed a strategic commercialisation agreement for its lead asset, ST10-021, an iron therapy product which has commenced Phase III clinical development, with AOP Orphan Pharmaceuticals AG.
› Verified 3 days ago
- 1
- 2(current)